HCPLive.com
HCPLive Podcasts
Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.
Be sure to visit the podcast's website and support the creator: www.hcplive.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Multi-System Approaches to Treating Pediatric Morphea 09.06.2022 9:08
In recognition of National Scleroderma Awareness Month, HCPLive spoke with several prominent dermatologists today who addressed some of the concerns and advancements related to the rare, multi-system disease. Scleroderma is often referred to as “morphea” by dermatologists, and the condition typically presents with the tightening and hardening of the skin. Depending on the region of the body, it ca...
Rare Disease Report: Myelodysplastic Syndromes & Acute Myeloid Leukemia 03.06.2022 22:57
Mikkael Sekeres, MD, is no stranger to rare disease. In his own words, there are rare diseases and then there are very rare diseases. Sickle cell is a rare condition with an incidence rate of just over 100 per 100,000 people. Sekeres focuses much of his treatment on patients with bone marrow disorders like myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). These conditions have an i...
How Tapinarof Cream 1% is Set to Revolutionize Psoriasis Care 01.06.2022 23:57
Last week , the US Food and Drug Administration approved tapinarof cream, 1% (VTAMA) for the treatment of plaque psoriasis of all severities in adult patients, ushering in the first and only FDA-approved steroid-free topical medication in its class. Remarkably, it had been 25 years since a novel chemical entity had been introduced into psoriasis care from a brand-new mechanism of action, and from...
Improving Screening Strategies for Cardiac Sarcoidosis 23.05.2022 9:02
In recent years, the acknowledgement of cardiac involvement in patients with sarcoidosis has become increasingly important. Thanks to advanced screening techniques, new research has suggested that approximately 2-5% of patients with sarcoidosis also struggle with cardiac sarcoidosis. However, the practice of adding echocardiography and ambulatory ECG to standard screening with the intention of ide...
What's Limiting Medical Marijuana Therapy in Rheumatology? 19.05.2022 23:15
Benjamin Nowell, PhD, and Stuart Silverman, MD, FACP, FACR, discuss the recent publication of a new review article, “Cannabis for rheumatic disease pain: A review of current literature.” Investigators discovered that progress in understanding cannabis-based therapies for treating the pain associated with rheumatic disease is hindered due to a lack of standardization of clinical research and curren...
Improving the Availability of COVID-19 Therapeutics in Vulnerable Communities 12.05.2022 16:03
Beyond vaccination, what are some methods for treating COVID-19 in both inpatient and outpatient settings? In the 2 years since the beginning of the pandemic, the strategies for protecting people from this deadly virus have certainly evolved, yet questions remain regarding COVID-19 therapeutics and their availability in certain communities and during times of scarcity. For this episode of DocTalk,...
A Medical Volunteer at the Ukraine-Poland Refugee Border 09.05.2022 11:45
Today's episode features Selena S. Li, MD, a Massachusetts General Hospital surgery resident, who recently traveled overseas with a volunteer medical group to provide treatments and care to refugees escaping the Russian invasion. For more clinical news and expert interviews, visit us at HCPLive.com. To learn more about donating to or volunteering with Medical Volunteers International, click here.
New Methods for Overcoming Environmental and Food Allergies 04.05.2022 11:56
When it comes to allergies, the number of affected individuals in the United States alone is staggering. Approximately 20 million adults and 6 million children in the US are affected by seasonal allergies, and roughly 32 million Americans struggle with a myriad of food allergies. Seasonal allergies have been front-of-mind for many Americans, especially with the Spring season in full effect. The st...
Evaluating the Efficacy of Faricimab in Patients with DME from Underrepresented Communities 02.05.2022 14:20
The newly approved ophthalmic drug faricimab (Vabysmo) has already made waves by being the first of its drug class to be approved for both diabetic macular edema (DME) and neovascular age-related degeneration (nAMD). A new phase 4 clinical trial from Genentech seeks to expand on the efficacy of the drug in patients with DME from underrepresented populations. The efficacy and safety of faricimab wi...
Rare Disease Report: TANGO2 28.04.2022 32:01
In this hallmark episode, we discuss a condition that has only been documented in 70 cases worldwide. Dr. Amelle Shilligton is a clinical geneticist at Cincinnati Children's Hospital Medical Center. In this conversation, Ashley and Jacob Wiley share the story of how they rushed their 15 month old daughter Aislynn to that hospital, and Dr. Shillington explains how she eventually solved the mystery...
How Determi-Nation Promotes Diversity in Psoriatic Research and Treatment 28.04.2022 16:52
When addressing psoriatic disease, it is important to consider how it uniquely affects people with skin of color. People from different racial and ethnic groups often struggle with psoriatic disease due to delays in diagnosis, misdiagnosis, and limited access to diagnostic testing and treatment. Furthermore, the lack of access to care and treatment has resulted in biologic use being 69% lower in p...
NAFLD Prevalence Increasing in Pediatric Patients 26.04.2022 9:03
Last week, a new investigation confirmed a higher prevalence of non-alcoholic fatty liver disease (NAFLD) in pediatric patients than previously thought. The data was part of the ongoing observational study called TARGET-NASH, which included participants with NAFLD and/or alcoholic steatohepatitis (NASH). The study, which included 660 pediatric patients, cited an increase in liver disease following...
Approximately 9 Million More Americans Exposed to Air Pollution in 2022 20.04.2022 23:05
Today, the American Lung Association released the 23rd annual “State of the Air” report, which detailed the nationwide exposure to ozone and particle pollution in the United States in 2022. The new report revealed that approximately 9 million more people were affected by particle pollution since last year’s report, with more reported days with “very unhealthy” and “hazardous” air quality than ever...
How JAK Inhibitors Revolutionized Dermatology Care 19.04.2022 14:20
Last summer, Derm Discussions host Brad Glick, DO, invited Brett King, MD, PhD, Yale School of Medicine, to the program to discuss an emerging class of dermatology therapy known as Janus kinase (JAK) inhibitors. At the time, small molecule drugs such as upadacitinib (Rinvoq) were approved for the treatment of conditions like rheumatoid arthritis and ulcerative colitis. Since then, updacacitinib an...
Exploring New Possibilities in Vitiligo Therapy 19.04.2022 10:59
An estimated 2 million patients in the United States have vitiligo, which is a dermatologic condition defined by depigmentation of the skin. Though there is currently no cure, recent medical advancements have helped patients and providers alike gain a broader perspective on the skin condition. Likewise, prominent cultural figures with vitiligo have also contributed addressing the stigma surroundin...
Addressing Rising Insomnia Rates in the United States 11.04.2022 14:33
Last week, the Alliance for Sleep committee announced new data from the largest sleep-based survey in the US, which found that 70% of people with trouble sleeping due to insomnia were “desperate to find a solution”. Insomnia affects approximately 25 million adults in the US, and is partially responsible for the roughly $7 billion spent annually on products or sleep aids such as blackout curtains,...
Overdrive Podcast: ArthritisPower Redesign and Research 11.04.2022 20:17
Dr. Benjamin Nowell and David Curtis chat about the the recent press release that CreakyJoints published addressing updates to their ArthritisPower interface in order to improve the user’s experience, including incorporating patient perspectives. They discuss how the changes will help both patients and rheumatologists alike, recent research, and what we have to look forward to in the near future....
Introducing Insulin Therapy and Dietary Care to Patients with Diabetes 06.04.2022 23:03
As diabetes care continues to evolve, especially in regard to insulin therapies, so too must the conversations being had between patients and doctors. Fortunately, a recent webinar titled “Institutional Perspectives in Diabetes: New Advances in Insulin Therapy for the Management of Type 2 Diabetes” hosted a myriad of thoughtful discussions regarding the importance of insulin therapies for diabetes...
Diagnosing and Treating Rosacea : An Overview 04.04.2022 11:26
April is Rosacea Awareness Month! While the cause of rosacea is still unknown, what is known is that it is estimated to affect up to 16 million people in the United States alone. Additionally, a recent survey by the National Rosacea Society indicated that 47% of affect patients were unaware of the disorder prior to their diagnosis, and 95% stated that they knew very little about the signs and symp...
Why Dermatologists Diagnose Psoriasis Less in Black Patients 26.03.2022 13:27
Coming live from the American Academy of Dermatology (AAD) 2022 Meeting in Boston, managing editor Kevin Kunzmann sits down with investigators from University of Perelman School of Medicine to discuss new data showing disparities in psoriasis diagnoses by race, and how dermatologists can become more confident in identifying new cases.
Rare Disease Report: Relapsing Polychondritis 25.03.2022 24:22
For Autoimmune Disease Awareness Month, Joe Ahearn, MD, discusses relapsing polychondritis from a clinical perspective with Michael Linn, an advocate and the Vice Chair of the Relapsing Polychondritis Foundation. The team shares an exciting announcement about the partnership they've formed.
Improving Racial and Ethnic Representation in Pediatric Trials 24.03.2022 9:32
Representation of different racial and ethnic groups in clinical trials has been an ongoing concern across all clinical fields, and pediatrics is no exception. A recent study from Emory University School of Medicine found that the number of pediatric clinical trials that reported participant race and ethnicity had increased from 2011 to 2020. However, participant race and ethnicity were still unde...
How Dermatologists Combat Misinformation on Social Media 17.03.2022 11:42
In recent years, the subject of misinformation has pervaded many of our conversations regarding world news, politics and more. But how might it affect dermatology care, especially in the realm of social media? A recent study from the University of California found that among 439 acne-related posts to the social media platform in April 2020, only 17 of the top posts came from dermatologists. The re...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.